Taofeek K. Owonikoko, MD/PhD

Citata da

	Tutte	Dal 2019
Citazioni	56950	48486
Indice H	90	78
i10-index	265	226

10000

5000

2500

7500

20112012201320142015201620172018201920202021202220232024143 247 361 518 879 1220 1565 2767 5212 7554 9267 9562 8983 7797

Accesso pubblico

Visualizza tutto

194 articoli

9 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Fadlo R. KhuriPresident and Professor, American University of BeirutEmail verificata su aub.edu.lb
nabil sabaProfessor and Vice Chair, Lynne and Howard Halpern Chair in Head and Neck Cancer ResearchEmail verificata su emory.edu
Walter CurranChief of Piedmont Oncology InstituteEmail verificata su piedmont.org
Dong Moon Shin, MD, FACPFrances Kelly Blomeyer Distinguished Chair in Cancer Research, Professor of Hematology and MedicalEmail verificata su emory.edu
Jonathan J BeitlerWinship Cancer Institute of Emory UniversityEmail verificata su emory.edu
Michael R. Rossi, Ph.D.VP Translational Science and Multimodal RWEEmail verificata su concertai.com
J. Trad Wadsworth, MD, MBA, FACSSenior Member, Department of Head and Neck-Endocrine Oncology, Moffitt CancerEmail verificata su moffitt.org
Camille RaginProfessor, Fox Chase Cancer CenterEmail verificata su fccc.edu
Suzanne DahlbergAssociate Professor, Harvard Medical School, Boston Children's HospitalEmail verificata su childrens.harvard.edu
Maohua XieJ. Mack Robinson College of Business, Georgia State UniversityEmail verificata su gsu.edu
Edmund K WallerEmory UniversityEmail verificata su emory.edu
John KauhTvardi TherapeuticsEmail verificata su tvardi.com
Mourad TighiouartProfessor, Cedars-Sinai Medical CenterEmail verificata su cshs.org
Johann BrandesTN Oncology, LLCEmail verificata su jhmi.edu
Paul W. DoetschNational Institute of Environmental Health SciencesEmail verificata su emory.edu
Wei ZhouEmory University School of MedicineEmail verificata su emory.edu
Dana NickleachSenior Statistician, IntrinsiQ Specialty SolutionsEmail verificata su intrinsiq.com
William A. Hall, MDMedical College of WisconsinEmail verificata su mcw.edu
Adebowale AkintayoPhysician, Emory UniversityEmail verificata su sph.emory.edu
Roshan Prabhu, MD, MScAtrium Health Levine Cancer / Southeast Radiation OncologyEmail verificata su sero.net

Segui

Taofeek K. Owonikoko, MD/PhD

University of Pittsburgh

Email verificata su upmc.edu - Home page

Translational oncology research lung cancer management experimental therapeutics


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	4830	2018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018	2910	2018
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015	2822	2015
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018	2727	2018
Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014	2689	2014
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018	2337	2018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018	2188	2018
Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018	1770	2018
Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017	1697	2017
PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma MR Migden, D Rischin, CD Schmults, A Guminski, A Hauschild, KD Lewis, ... New England Journal of Medicine 379 (4), 341-351, 2018	1389	2018
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018	986	2018
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent AO Kamphorst, A Wieland, T Nasti, S Yang, R Zhang, DL Barber, ... Science 355 (6332), 1423-1427, 2017	975	2017
Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018	957	2018
Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ... Cell reports 23 (1), 181-193. e7, 2018	913	2018
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018	895	2018
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ... Cell 171 (4), 950-965, 2017	888	2017
Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018	801	2018
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients AO Kamphorst, RN Pillai, S Yang, TH Nasti, RS Akondy, A Wieland, ... Proceedings of the National Academy of Sciences 114 (19), 4993-4998, 2017	794	2017
Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018	770	2018
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers LJ Wirth, E Sherman, B Robinson, B Solomon, H Kang, J Lorch, F Worden, ... New England Journal of Medicine 383 (9), 825-835, 2020	700	2020

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori